Delivery Order SPE2DB24D8001-SPE2DB25FLAMV
- Not listed
- This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2TM5, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,617.69 firm fixed-price delivery order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a period of performance through October 27, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.22 to Dakota Drug, Inc. on August 25, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place in Anoka, Minnesota. The award utilized no set-aside designation and represents a straightforward pharmaceutical procurement from Dakota Drug, Inc., a self-certified small disadvantaged...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,884.98 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of eluryng vaginal rings. This firm fixed price delivery order, issued on August 13, 2025, is set to be completed by August 14, 2025, and represents a continuation of services under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was not designated for any specific set-aside...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order valued at $2,308.14 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 2, 2025. This Firm Fixed Price delivery order, issued without set-aside designation, represents a task order under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $2,848.29 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count). This firm fixed price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-set-aside award. The contract will be performed at Dakota Drug's Anoka facility. This delivery order falls under Dakota Drug's...
- The Defense Logistics Agency awarded a $1,534.76 delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packaging). The contract is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and was issued without a set-aside designation. Dakota Drug, Inc. is performing this work at its Anoka, Minnesota location as part of its broader role supplying pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,584.98 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). The contract is priced on a firm fixed-price basis with an ultimate completion date of August 22, 2025, and was awarded on August 21, 2025. This delivery order carries no set-aside designation and represents a straightforward pharmaceutical procurement...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical division, awarded a Firm Fixed Price delivery order contract valued at $4,787.60 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS medical supplies, with a performance period extending through April 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,699.40 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. This delivery order, which was not set aside, is part of a larger Indefinite Delivery Contract (IDC) identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC allows Dakota Drug to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $11,449.26 firm fixed-price delivery order is for the supply of pharmaceutical products, specifically LO LOESTRIN FE 1-10 tablets, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLAMVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,230.94 to Dakota Drug, Inc. on September 23, 2025, for the supply of Cryselle-28 tablets. This firm fixed price delivery order will be completed by September 24, 2025, and will be performed in Anoka, Minnesota. The award carries no set-aside designation and represents a continuation of the DLA's medical supply procurement activities through existing contract vehicles. Dakota Drug, Inc., a self-certified small disadvantaged business, serves as the prime contractor and has established itself as a critical pharmaceutical supplier to the DLA. The company operates under a larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999.99 million with DLA Troop Support Medical's ECAT Generation V Program, which runs through December 31, 2025. This program supports the procurement of pharmaceutical products, medical supplies, and healthcare equipment for U.S. Armed Forces medical operations. Through this delivery order structure, Dakota Drug continues to fulfill essential medication requirements for military healthcare facilities, with this particular order addressing hormonal treatment needs within the federal defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/23/25 |